CWM, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 98 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
CWM, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2
+100.0%
202
+149.4%
0.00%
Q2 2023$1
-80.0%
81
-72.5%
0.00%
Q1 2023$5
+66.7%
295
+104.9%
0.00%
Q4 2022$3144
+526.1%
0.00%
Q3 2022$0230.0%0.00%
Q2 2022$0
-100.0%
23
-95.6%
0.00%
Q1 2022$4,0000.0%5230.0%0.00%
Q4 2021$4,000
-20.0%
523
-33.8%
0.00%
Q2 2021$5,0000.0%7900.0%0.00%
Q1 2021$5,0000.0%7900.0%0.00%
Q4 2020$5,0000.0%7900.0%0.00%
Q3 2020$5,0000.0%7900.0%0.00%
Q2 2020$5,0000.0%7900.0%0.00%
Q1 2020$5,0000.0%7900.0%0.00%
Q4 2019$5,0000.0%7900.0%0.00%
Q3 2019$5,0000.0%7900.0%0.00%
Q2 2019$5,0000.0%7900.0%0.00%
Q1 2019$5,000
+400.0%
790
+58.0%
0.00%
Q4 2018$1,000
-50.0%
5000.0%0.00%
Q3 2018$2,0000.0%5000.0%0.00%
Q2 2018$2,000
+100.0%
5000.0%0.00%
Q1 2018$1,000
-50.0%
5000.0%0.00%
Q4 2017$2,000
+100.0%
5000.0%0.00%
Q3 2017$1,0000.0%5000.0%0.00%
Q2 2017$1,0000.0%5000.0%0.00%
Q1 2017$1,0000.0%5000.0%0.00%
Q4 2016$1,0000.0%5000.0%0.00%
Q3 2016$1,0005000.0%0.00%
Q2 2016$0
-100.0%
5000.0%0.00%
Q1 2016$1,0000.0%5000.0%0.00%
Q4 2015$1,000
-50.0%
5000.0%0.00%
Q3 2015$2,0005000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$1,902,0005.68%
GABLES CAPITAL MANAGEMENT INC. 433,814$5,566,0004.46%
Quantedge Capital Pte Ltd 503,700$6,462,0001.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,896,000$62,816,0001.25%
Lanham O'Dell & Company, Inc. 20,145$258,0000.92%
Capital Impact Advisors, LLC 59,301$907,0000.90%
SummerHaven Investment Management, LLC 98,840$1,268,0000.88%
Yorktown Management & Research Co Inc 50,000$642,0000.83%
GLOBEFLEX CAPITAL L P 304,293$3,904,0000.67%
AFFINITY INVESTMENT ADVISORS, LLC 90,864$1,166,0000.60%
View complete list of CATALYST PHARMACEUTICALS INC shareholders